being and becoming in the world

About me
being and becoming
in the world
Mind The Gap
where time passes (listen)

Search for:

By Hole Ousia Posted on July 20, 2023

Estimating the true value: Aducanumab and Donanemab for Early Alzheimer Disease

Categories: Alzheimer's disease, Dementia, History of medicine, Medical Education, Medical humanities, Pharmaceutical industry and Medical Education, PsychiatryTags: 'The Edinburgh Consensus: Preparing for the advent of disease-modifying therapies for Alzheimer's disease' Alzheimer's research & therapy, 17 July 2023, a drug that is not effective cannot be cost-effective, accelerated approval pathway, Aducanumab and Donanemab for Early Alzheimer Disease: Estimating the true value, Alzheimer, Alzheimer Society, Alzheimer's, Amar H kelkar, amylod, amyloid cascade, AMYVID, BBC, brain swelling, cost-effectiveness of Aducanumab and Donanemab, Craig Ritchie, Dawn A Brooks, Dawn Brooks, Dementia, Dementia expert Professor Craig Ritchie quits NHS job, Donanemab, Donanemab in Early Symptomatic Alzheimer Disease, Dr Peter Gordon, early Alzheimer's disease, early diagnosis, Edinburgh Consensus, Edward R Scheffer Cliff, Eli Lilly, Eric L Ross, Estimating the true value: Aducanumab and Donanemab for Early Alzheimer Disease, Express, FDA, headlines, Hole Ousia, immunoglobulin G1, infusion, Issues not considered in the 'Edinburgh Consensus', John R Sims, Marc S Weinberg, MCI, MHRA, Mirror, monoclonal antibody, New York Times, newspaper reports, NICE guidelines, Phase 3, prevention, Professor Craig Ritchie, public health, radio 4, RCT, rebel antiquary, regulatory approval, scanners, Scottish Brain Sciences, Sky News, Soeren Mattke, Steven E Arnold, tau, The Edinburgh Consensus, The Guardian, The Rebel Antiquary, The World Tonight, trailblazer, TRAILBLAZER-ALZ 2, treatments for Alzheimer's disease, US Food and Drug Administration

Post navigation

Previous Post Previous post:Anti-amyloid immunotherapies: low benefit/risk ratio

Next Post ‘Therapy related brain damage’

Recent Posts

Heart of Darkness
dead sure
The “manager himself”
White ivory had been replaced
postscriptum
an idea
Screaming mouth
How many bite the hand that feeds them?
Now over ONE MILLION
Group bullying
Béatrice
poetic fragments scattered in the streets
Scotland and Tonga
Röntgen
Rapid response
Unethical pharmaceutical marketing: a common problem requiring collective responsibility
weakness
Wrap-around advertising
“Would be difficult to navigate and impossible to regulate”
Sixty seconds on . . . movie credits
Living with uncertainty
sticks + stones
Enter your answer here
Uncle Feedle’s fourth kind of vision
Love catch these fragments:
some kind of poem
“the heathery knows”
On the values of trust and kindness
from our own weakness
kindness
The other me
Clock delinquency
Deborah Levy
no more to her
Not a true picture.
Poems on the Carron valley
“How are you getting on with that abandoned farm you bought?”
“We strive to uphold everyday”
our stories about the world
rest assured
a portrait
Peter on sunshine
Consultation on Sunshine legislation
“Psychedelic drugs could soon treat alcoholism”
senility
Cathedral of trees
Strathcarron [a few of my films]
The vision of Mr Dun
As that swift eternity ended
sadly missed
“The biggest effect on human health is commercial determinants”
Adverts for ‘Scottish Brain Sciences’
the most attractive way possible
ALARMS IGNORED
formerly known as
Tattie hairst
a few favourite films
old shepherd’s death
rest your head
Viaduct to be closed.
The sky is living here today
Chapel [site of]
‘To assist in dispensing’
This house isn’t empty it is full of dreams
A name for a new ferry?
Television YESTERDAY
that cosmic Utopian tale
The very first ‘selfie’
“groupthink”
friendship itself
natural globes of wonder
‘He believed there was only one culture’
Do doctors need to be told to be kind?
Forfarshire’s largest tree cut down
sort of navigating
The felt life
Inmate No. P01135809
more spacious
Nothing like this had ever happened [Absent gods]
barely a dozen people gathered to pay their last respects
‘The last grave’
Grey will match your eyes perfectly
For men who enjoy power
JOIN the MONEY BUILDERS
Beautifully fast
The Clerihew
‘incarnate in an irresistible dictatorship’
the Specksynder or Chief Harpooneer
Moby Dick
Ragnarök
There’s an art to that
An hour with Alexander McCall Smith
The case for kindness
Royal colleges are urged to be more transparent on industry payments
LESSONS
AWARD CULTURE
It’s important to be yourself.
‘make bodies expressive of feeling’
a crumpled piece of A4!
overstuffed
simple starting positions
Future generations
Now called ‘X’
Together
80 SHEET PAD
ILFORD
CRYSTALLEX
The real us
Little globes of Wonder
Seven Sisters Oak
Trunk of an Oak Tree
alone
QUOTES OF THE WEEK
“For doctors on social media”
“Shirking a leadership responsibility”
Ashes: the Bonhill Ash trees
Adam and Eve [Eden Place, Rothesay]
“Make ends meet”
The Yellow Gowan Tree
The Chapel Tree: ‘Early Man in the Scottish Landscape’
THE BLUEBELLS [in the 21st century]
BLINK
NOTICE BOARD
The Dule Tree[s] of Newark Castle
The Tree of Mains
A College Spokesperson
Shame on us all
Defensive
Professor David Nutt: “The race is on to get it to market”
“BAPFEST”
Mossgrove sweet peas
How brightly
5 Live Science: Tackling Depression
Moderate to severe depression: No evidence that CBT is less effective than antidepressants
Published letters on the ANTLER Trial
The ANTLER trial
A Survey of the provision of support and withdrawal services for patients dependent on prescription drugs
Misuse of influence
“The RULES of SCIENCE”
150 reports of possible cases of self-injury and suicidal thoughts
HTA-SADD: “There were more adverse reactions in individuals treated with antidepressants than there were with placebo”
“Questioning the Journal’s independence and lack of scientific explanation in the College’s response”
“80% might be false positive”
“The hyperbole in the media and scientific response is unjustified and cruel to patients”
happy vagabundance
Joint Letter by Alzheimer’s Scientists
“The data point to beta-amyloid playing a minor aetiological role”
‘Therapy related brain damage’
Estimating the true value: Aducanumab and Donanemab for Early Alzheimer Disease
Anti-amyloid immunotherapies: low benefit/risk ratio

1-202-555-1212

peter@holeousia.com

Pages

About me
being and becoming
in the world
Mind The Gap
where time passes (listen)

Share this:

Leave a ReplyCancel reply